Drug price advertising transparency may not have the effect Trump wants, says pro

2:44 PM ET Tue, 16 Oct 2018

David Maris, Wells Fargo Securities, discusses the potential impact on pharma companies should the Trump administration's push for drug price transparency in advertising come to pass.